Administration schedule and ototoxicity of amikacin in children with cancer. 2014

Elio Castagnola, and Sandro Dallorso, and Riccardo Haupt
Infectious Diseases Unit, Istituto Giannina Gaslini, Genoa, Italy.

UI MeSH Term Description Entries
D008297 Male Males
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000583 Amikacin A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics. A.M.K,Amikacin Sulfate,Amikacina Medical,Amikacina Normon,Amikafur,Amikalem,Amikason's,Amikayect,Amikin,Amiklin,Amukin,BB-K 8,BB-K8,Biclin,Biklin,Gamikal,Kanbine,Oprad,Yectamid,BB K 8,BB K8,BBK 8,BBK8,Medical, Amikacina,Normon, Amikacina,Sulfate, Amikacin
D000617 Aminoglycosides Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS. Aminoglycoside
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D015837 Vestibular Diseases Pathological processes of the VESTIBULAR LABYRINTH which contains part of the balancing apparatus. Patients with vestibular diseases show instability and are at risk of frequent falls. Disease, Vestibular,Diseases, Vestibular,Vestibular Disease
D034381 Hearing Loss A general term for the complete or partial loss of the ability to hear from one or both ears. Deafness, Transitory,Hearing Impairment,Hearing Loss, Transitory,Hypoacusis,Transitory Hearing Loss,Deafnesses, Transitory,Hypoacuses,Loss, Hearing,Loss, Transitory Hearing,Transitory Deafness,Transitory Deafnesses,Transitory Hearing Losses

Related Publications

Elio Castagnola, and Sandro Dallorso, and Riccardo Haupt
February 2014, Pediatric blood & cancer,
Elio Castagnola, and Sandro Dallorso, and Riccardo Haupt
January 1990, ORL; journal for oto-rhino-laryngology and its related specialties,
Elio Castagnola, and Sandro Dallorso, and Riccardo Haupt
June 1976, Antimicrobial agents and chemotherapy,
Elio Castagnola, and Sandro Dallorso, and Riccardo Haupt
April 2010, International journal of pediatric otorhinolaryngology,
Elio Castagnola, and Sandro Dallorso, and Riccardo Haupt
January 1993, Developmental pharmacology and therapeutics,
Elio Castagnola, and Sandro Dallorso, and Riccardo Haupt
April 2015, The Annals of otology, rhinology, and laryngology,
Elio Castagnola, and Sandro Dallorso, and Riccardo Haupt
January 1982, Clinical pharmacy,
Elio Castagnola, and Sandro Dallorso, and Riccardo Haupt
January 1990, Acta oto-laryngologica,
Elio Castagnola, and Sandro Dallorso, and Riccardo Haupt
May 1977, The New England journal of medicine,
Elio Castagnola, and Sandro Dallorso, and Riccardo Haupt
January 1979, Infection,
Copied contents to your clipboard!